Bruker Reports Second Quarter 2021 Financial Results

Q2 2021 revenue growth of 34.4% year-over-year; organic revenue growth of 27.2% Q2 2021 GAAP EPS of $0.38; non-GAAP EPS of $0.44, compared to $0.21 in Q2 2020 Strong financial performance in the Bruker Scientific Instruments and BEST businesses drives a further increase in fiscal year 2021 guidance BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR)... Read more

WITec alpha300 [i]apyron[/i] wins 2021 Microscopy Today Innovation Award

The fully automated Raman microscope is deemed one of the year’s best developments. Ulm, Germany August 2, 2021 WITec GmbH, the prime mover of technological advance in commercial Raman microscopes, has received a 2021 Microscopy Today Innovation Award for its alpha300 apyron fully automated Raman imaging system. It was selected by the editors of Microscopy Today... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted restricted stock units (“RSUs”) covering 29,500 shares of Pacific Biosciences common stock, to a... Read more

PerkinElmer Announces Financial Results for the Second Quarter of 2021

Revenue of $1.228 billion; 51% reported growth; 41% organic growth GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83 Initiates Third Quarter and Raises Full-Year Revenue and Earnings Guidance Announces Agreement to Acquire BioLegend – Leading Antibody & Research Reagent Provider Earnings Call Moved to Today at 8:00 a.m. Eastern Time; Dial-in Information... Read more

PerkinElmer’s COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type

Non-invasive sampling method makes it easier to use the highly sensitive molecular test manufactured by PerkinElmer WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the U.S. Food and Drug Administration (FDA) has authorized the PerkinElmer® New Coronavirus Nucleic Acid Detection Kit for an additional indication that permits... Read more